Starling Oncology, Inc.: common_shares_issued
| Value | {"unit": "shares", "value": 73754609, "concept": "us-gaap:CommonStockSharesIssued"} |
|---|---|
| Period | (as of 2023-03-31) |
| Status | current |
| Entity | Starling Oncology, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:08:38.724184+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/97e997eb-538c-4255-9240-f869e585d0cf
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001628280-23-017229Retrieved: 2026-08-19T18:08:38.724184+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001799191/common-shares-issued/2023-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/97e997eb-538c-4255-9240-f869e585d0cf
History
- no predecessors — first report